Pancreatic Cancer Research

ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Oliver Stoeltzing

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5007121961. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers

Papers 3

  1. STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. Co-author DOI 10.1593/neo.12878↗
  2. Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. Last author PMID 22753713↗
  3. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-11-0312↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sven Arke Lang · 3 shared papers, 2011–2012 · strength 0.09
  2. Christian Moser · 3 shared papers, 2011–2012 · strength 0.09
  3. Christina Hackl · 2 shared papers, 2012 · strength 0.06
  4. Johannes Taeger · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.